Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
D015126:8,11,14-Eicosatrienoic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism; D003094:Collagen / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated / Q000031:analogs & derivatives* / Q000097:blood; D006801:Humans; D008042:Linolenic Acids / Q000378:metabolism; D010545:Peroxides / Q000097:blood; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000097:blood; D011458:Prostaglandins E / Q000096:biosynthesis; D051381:Rats; D013927:Thrombosis / Q000517:prevention & control
D001095:Arachidonic Acids; D005231:Fatty Acids, Unsaturated; D008042:Linolenic Acids; D010545:Peroxides; D011453:Prostaglandins; D011458:Prostaglandins E; D000244:Adenosine Diphosphate; D003094:Collagen; D015126:8,11,14-Eicosatrienoic Acid; D004837:Epinephrine